Skip to content
Genetic Analysis
Genetic Analysis
  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • Analyst Coverage
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us
Genetic Analysis
  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • Analyst Coverage
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us

Press Releases

Genetic Analysis and Servatus enter Strategic Collaboration Agreement to develop new microbiome diagnostic and therapeutic solutions

2022-06-22

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

2022-05-20

Genetic Analysis AS and Omnigene Medical Technologies Ltd. enter a distribution agreement to launch GA-map® in the United Arabic Emirates (UAE) market

2022-05-19

Interim report January – March 2022

2022-05-13

Minutes from the Annual General Meeting 2022 in Genetic Analysis AS

2022-04-29

Publication of Genetic Analysis’ 2021 Annual Report

2022-04-21

Notice of Annual General Meeting 2022

2022-04-21

Genetic Analysis strengthens its management team by hiring a Head of Operations

2022-03-04

Year-End Report October – December 2021

2022-02-18

IMD – Institut für Medizinische Diagnostik launches the GA-map® Microbiome Test in Germany

2022-02-15
Post navigation
Older posts
Page1 Page2 … Page4 Next →

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Kabelgata 8
0580 Oslo, Norway

Open Google Maps
Connect

LinkedIn

Facebook

Twitter

Navigate

Contact Us

Terms of Use

Privacy Policy

© 2021 Genetic Analysis

  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • Analyst Coverage
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us